Semperit AG Holding

EANS-Adhoc: Semperit AG Holding
Successful Start in 2014 (with photo)

--------------------------------------------------------------------------------
  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.
--------------------------------------------------------------------------------
Financial Figures/Balance Sheet/quarterly report
20.05.2014


* Revenue up 8.1% in Q1 2014 to EUR 232.7 million
* Significant rise in EBITDA (+14.0%) and EBIT (+18.9%) 
* Growth and enhanced profitability in both sectors 
* Continuation of the good order situation expected

Vienna, May 20, 2014 - The publicly listed Semperit Group recorded the best
first-quarter result in the company's history during the first three months of
2014, achieving significant increases in revenue and earnings. Revenue in the
first quarter of 2014 rose 8.1% year-on-year to EUR 232.7 million from EUR 215.2
million in the prior-year period. Both Medical and Industrial Sectors
contributed to growth based on strong sales performances and higher global
sales. The Medical Sector once again expanded faster than the market. The more
cyclically-dependent Industrial Sector succeeded in further increasing revenue
and profitability. 

In the first quarter of 2014, the Group's consolidated EBITDA improved by 14.0%
to EUR 33.4 million from EUR 29.3 million in the previous year. EBIT climbed by
18.9% to EUR 22.3 million compared to the prior-year level of EUR 18.8 million.
In addition to the strong operating development, the resolute implementation of
strategic raw material management, stringent cost discipline and further
efficiency improvements contributed to the rise in earnings. The EBITDA margin
was up from 13.6% to 14.4%, and the EBIT margin climbed to 9.6% from 8.7% in the
previous year. Semperit achieved a net result (earnings after tax) of EUR 13.1
million, constituting an increase of 5.0% from the comparable level of EUR 12.5
million in the first quarter of 2013.   

"We grew faster than the market in the first quarter of 2014 because we
succeeded in massively strengthening and further internationalising our sales
activities. We expanded our product portfolio by adding new products which have
been successful in the marketplace, and intensified our customer service. We are
attracting new key accounts and further expanding the business with our existing
customers", says Semperit CEO Thomas Fahnemann in assessing the current business
development. "With respect to costs, we are profiting from the active management
of our raw material needs as well as high capacity utilisation. The bottom line
is that the good quarterly result was driven less by market growth than by the
implementation of strategic measures", CEO Fahnemann adds.  

Semperit continued to boast a sound capital base at the reporting date of March
31, 2014. The equity ratio remained at the high level of 49.0% compared to 48.3%
at the end of 2013. Cash and cash equivalents rose from EUR 182.6 million at
year-end 2013 to EUR 188.1 million due to the strong operating cash flow
generation. "Semperit has operated successfully, and we are a sound footing
financially. We are more or less debt-free thanks to our strong cash position,
and still have a positive net liquidity of EUR 51.4 million after deducting the
financing liabilities. As a consequence, the financing of future growth
activities is secured", explains Semperit CFO Johannes Schmidt-Schultes.

Medical Sector: Substantial revenue and earnings increases
In the Medical Sector (the Sempermed segment), the intensified sales activities
resulted in a considerable rise in sales volumes. Therefore, the ongoing
negative price effects caused by the lower raw material prices were more than
offset. Demand for examination gloves in Europe and Asia was good. In
particular, sales showed a particularly positive development in the industrial
and consumer goods sectors. The capacity at the Sempermed production plants was
well utilised as in previous quarterly periods.  

Revenue of the Medical Sector rose 6.9% in the first quarter of 2014 to EUR
114.1 million. EBITDA was up 28.9% to EUR 15.8 million, providing an improved
EBITDA margin of 13.8% compared to 11.5% in the prior year. 

Industrial Sector: Further increase in profitability
The Industrial Sector (the Semperflex, Sempertrans and Semperform segments)
generated further revenue and earnings growth. All three segments further
increased sales volumes, which can be mainly attributed to the expansion of
sales activities and the high acceptance of new products on the part of
customers. This served as the basis for opening up new markets and gaining
market shares. 


In the Semperflex segment, sales successes and a very good capacity utilisation
of production plants led to substantial revenue and earnings growth. The
hydraulic hose business in Europe developed very well, whereas momentum picked
up in the American market. Demand for industrial hoses in most European markets
was very satisfactory, and the globalisation drive showed further success. The
Sempertrans segment achieved volume growth, especially for higher-priced product
groups. High demand in Europe, South America and Africa resulted in the full
capacity utilisation of its European production plants. However, negative raw
material price effects led to a decline in revenue and earnings. The Semperform
segment generated double-digit volume growth by gaining market shares.         

Revenue of the Industrial Sector rose 9.4% in the first quarter of 2014 to EUR
118.6 million. EBITDA was up 14.4% to EUR 23.2 million, corresponding to an
excellent EBITDA margin of 19.6% compared to 18.7% in the prior-year quarter.
Double-digit EBIT margins were achieved in all three segments. 

Outlook 2014 and multi-year targets

The Semperit Group expects a continuation of the current good level of incoming
orders for the rest of 2014 as well as a satisfactory development of revenue and
earnings compared to 2013. The Industrial Sector is currently profiting from
good demand in all segments. The Medical Sector should continue on its dynamic
growth path which is not tied to overall economic growth. 

The focus of the Sempermed segment will be on further enhancing the efficiency
of the individual production plants and the overall profitability of the
segment. The Semperit Group assumes that global demand for examination and
protective gloves will continue to rise.  

A stable development is expected in the Industrial Sector in 2014 due to the
fact that production capacities are already being very well utilised in all
three segments. The expansion of capacities for hydraulic and industrial hoses
in Odry, Czech Republic and conveyor belts at the Belchatów site in Poland is
proceeding on schedule. The additional production capacities will first be
available in the first half of 2015.  

Semperit plans to invest about EUR 50-60 million to boost production capacities
and maintain its existing facilities.  

The Semperit Group reaffirms its previous growth targets of generating
double-digit revenue growth on average in the years from 2010 to 2015. The
Semperit Group still aims to achieve an EBITDA margin ranging between 12% and
15% and an EBIT margin of between 8% and 11% in the coming years.  

The report on the first quarter of 2014 is available for download at
{http://www.semperitgroup.com/en/ir/publications/quarterly-reports/}[HYPERLINK:
http://www.semperitgroup.com/en/ir/publications/quarterly-reports/]

About Semperit 
The publicly listed company Semperit AG Holding is an internationally-oriented
group that develops, produces, and sells in more than 100 countries highly
specialised rubber and plastic products for the medical and industrial sectors:
examination and surgical gloves, hydraulic and industrial hoses, conveyor belts,
escalator handrails, construction profiles, cable car rings, and products for
railway superstructures. The headquarters of this long-standing Austrian
company, which was founded in 1824, are located in Vienna, and the global R & D
centre is in Wimpassing, Lower Austria. The Semperit Group employs about 10,800
people worldwide, including more than 7,000 in Asia and more than 700 in Austria
(Vienna and production site in Wimpassing, Lower Austria). The Group has 22
manufacturing facilities worldwide and numerous sales offices in Europe, Asia,
and America. In 2013 the group generated sales of EUR 906 million and an EBITDA
of EUR 133 million.

Pictures with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/9MBuFHQS
http://resources.euroadhoc.com/us/iVsYiznE

Further inquiry note:
Martina Büchele 		
Head of Group Communications
Tel.: +43 676 8715 8621		
martina.buechele@semperitgroup.com
www.semperitgroup.com

Stefan Marin	
Investor Relations	
Tel.: +43 676 8715 8210
stefan.marin@semperitgroup.com

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


Pictures with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/9MBuFHQS
http://resources.euroadhoc.com/us/iVsYiznE


issuer:      Semperit AG Holding
             Modecenterstrasse 22
             A-1030 Wien
phone:       +43 1 79 777-210
FAX:         +43 1 79 777-602
mail:     investor@semperitgroup.com
WWW:      www.semperitgroup.com
sector:      Synthetics & Plastics
ISIN:        AT0000785555
indexes:     WBI, ATX Prime, ViDX, Prime Market, ATX Global Players
stockmarkets: official market: Wien 
language:   English
 



Weitere Meldungen: Semperit AG Holding

Das könnte Sie auch interessieren: